Mr. Metselaar was trained as a pharmacist at the faculty of Pharmaceutical Sciences at the Utrecht University and invented the liposomal corticosteroid technology platform. From 2005 on he managed the company’s research projects, patent portfolio and daily operations. He leads the pharmaceutical development of the company´s proprietary technology into clinical applicable products.
Mr. Rutten has 17 years of experience in management, business development and marketing in the biotechnology industry. His previous experience include positions within large and small biotechnology organizations in the U.S., Netherlands, Asian Pacific, India, Canada, and Mexico. Mr Rutten currently is director of Clinquest Services, co-founder of Audion Therapeutics, a company targeting hearing loss and of Dybly, a cardiovascular therapeutics company based in Basel, Switzerland. Mr. Rutten received his Masters in Biotechnology from the University of Wageningen in the Netherlands.